{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,5]],"date-time":"2026-11-05T11:43:51Z","timestamp":1793879031075,"version":"4.7.0"},"reference-count":37,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,2,27]],"date-time":"2025-02-27T00:00:00Z","timestamp":1740614400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,2,27]],"date-time":"2025-02-27T00:00:00Z","timestamp":1740614400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"CSIR- Indian Institute of Chemical Biology- Internal Funding OLP121"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cell Death Dis"],"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:p>Ovarian cancer (OC) is an aggressive malignancy of the female reproductive organs, associated with a low 5-year survival rate. Emerging evidence suggests the pivotal role of microRNAs (miRNAs) in regulating chemoresistance and metastasis in OC, primarily through cancer stem cells (CSCs), also known as cancer stem-like cells (CSLCs). Herein, we demonstrate that miR-379-5p is downregulated in several OC cell populations including both cell lines and patient tumor samples. Furthermore, overexpression of miR-379-5p effectively inhibits CSCs and counteracts cisplatin-induced expansion of CSCs. Further mechanistic investigations identify RAD18, a DNA repair protein involved in translesion DNA synthesis (TLS), as a direct target of miR-379-5p. Moreover, a negative correlation between miR-379-5p and RAD18 expression is observed in ovarian CSCs isolated from OC patients. The downregulation of RAD18 inhibits stem-like phenotypes and enhances the sensitivity of ovarian CSCs to cisplatin treatment. Importantly, miR-379-5p-mediated inhibition of RAD18 prevents the repair synthesis in CSCs by promoting the accumulation of DNA damage. In vivo studies further reveal that miR-379-5p enhances DNA damage, which, in turn, inhibits tumor cell proliferation in athymic nude mice. Remarkably, targeting of RAD18 by miR-379-5p prevents monoubiquitination of proliferating cell nuclear antigen (PCNA), resulting in reduced DNA Polymerase \u03b7 (a TLS polymerase that helps to bypass DNA lesions) recruitment to lesion sites. In the absence of Pol\u03b7, the persisting DNA lesions cause activation of cell cycle arrest and apoptosis pathway in CSCs. Therefore, our findings unveil a novel mechanism whereby miR-379-5p overexpression curtails CSCs by modulating the RAD18\/Pol\u03b7 axis.<\/jats:p>","DOI":"10.1038\/s41419-025-07430-5","type":"journal-article","created":{"date-parts":[[2025,2,28]],"date-time":"2025-02-28T12:53:53Z","timestamp":1740747233000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":12,"title":["MicroRNA-379-5p attenuates cancer stem cells and reduces cisplatin resistance in ovarian cancer by regulating RAD18\/Pol\u03b7 axis"],"prefix":"10.1038","volume":"16","author":[{"given":"Devendra","family":"Shukla","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sanjay","family":"Mishra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tanima","family":"Mandal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manish","family":"Charan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ajeet Kumar","family":"Verma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8405-3262","authenticated-orcid":false,"given":"Md Maqsood Ahamad","family":"Khan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nabanita","family":"Chatterjee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amit Kumar","family":"Dixit","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Senthil Kumar","family":"Ganesan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2712-8680","authenticated-orcid":false,"given":"Ramesh K.","family":"Ganju","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4941-0591","authenticated-orcid":false,"given":"Amit Kumar","family":"Srivastava","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,2,27]]},"reference":[{"key":"7430_CR1","unstructured":"Arora T, Mullangi S, Vadakekut ES, Lekkala MR. Ovarian cancer. 2023 [cited 2023 Oct 24]. https:\/\/pubmed.ncbi.nlm.nih.gov\/33620837."},{"key":"7430_CR2","doi-asserted-by":"publisher","unstructured":"Ip CKM, Li SS, Tang MYH, Sy SKH, Ren Y, Shum HC, et al. Stemness and chemoresistance in epithelial ovarian carcinoma cells under shear stress. Sci Rep. 2016;6:26788. https:\/\/doi.org\/10.1038\/srep26788.","DOI":"10.1038\/srep26788"},{"key":"7430_CR3","doi-asserted-by":"publisher","unstructured":"Walcher L, Kistenmacher AK, Suo H, Kitte R, Dluczek S, Strau\u00df A, et al. Cancer stem cells\u2014origins and biomarkers: perspectives for targeted personalized therapies. Front Immunol. 2020;11. https:\/\/doi.org\/10.3389\/fimmu.2020.01280.","DOI":"10.3389\/fimmu.2020.01280"},{"key":"7430_CR4","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1593\/neo.131744","volume":"16","author":"C N\u00f6r","year":"2014","unstructured":"N\u00f6r C, Zhang Z, Warner KA, Bernardi L, Visioli F, Helman JI, et al. Cisplatin induces Bmi-1 and enhances the stem cell fraction in head and neck cancer. Neoplasia. 2014;16:137\u201346.","journal-title":"Neoplasia"},{"key":"7430_CR5","doi-asserted-by":"publisher","unstructured":"Louka M, Boutou E, Bakou V, Pappa V, Georgoulis A, St\u00fcrzbecher HW, et al. DNA damage response\/repair in cancer stem cells\u2014potential vs. controversies. In: Chen CC, editor. Advances in DNA repair. Rijeka: IntechOpen; 2015. p. 15. https:\/\/doi.org\/10.5772\/61355.","DOI":"10.5772\/61355"},{"issue":"2","key":"7430_CR6","doi-asserted-by":"publisher","first-page":"116","DOI":"10.1038\/nrm2621","volume":"10","author":"VK Gangaraju","year":"2009","unstructured":"Gangaraju VK, Lin H. MicroRNAs: key regulators of stem cells. Nat Rev Mol Cell Biol. 2009;10(2):116\u201325.","journal-title":"Nat Rev Mol Cell Biol"},{"key":"7430_CR7","doi-asserted-by":"publisher","unstructured":"Takahashi R u, Miyazaki H, Ochiya T. The role of microRNAs in the regulation of cancer stem cells. Front Genet. 2014;4. https:\/\/doi.org\/10.3389\/fgene.2013.00295.","DOI":"10.3389\/fgene.2013.00295"},{"key":"7430_CR8","first-page":"84","volume":"37","author":"C Guo","year":"2020","unstructured":"Guo C, Wang H, Jiang H, Qiao L, Wang X. Circ_0011292 enhances paclitaxel resistance in non-small cell lung cancer by regulating miR-379-5p\/TRIM65 axis. Cancer Biother Radiopharm. 2020;37:84\u201395.","journal-title":"Cancer Biother Radiopharm"},{"key":"7430_CR9","doi-asserted-by":"publisher","DOI":"10.1038\/s41419-019-2213-x","volume":"11","author":"W Ji","year":"2020","unstructured":"Ji W, Diao YL, Qiu YR, Ge J, Cao XC, Yu Y. LINC00665 promotes breast cancer progression through regulation of the miR-379-5p\/LIN28B axis. Cell Death Dis. 2020;11. 16.","journal-title":"Cell Death Dis"},{"key":"7430_CR10","doi-asserted-by":"publisher","first-page":"987","DOI":"10.3727\/096504017X15140534417184","volume":"26","author":"X Shi","year":"2018","unstructured":"Shi X, Xiao X, Yuan N, Zhang S, Yuan F, Wang X. MicroRNA-379 suppresses cervical cancer cell proliferation and invasion by directly targeting V-crk avian sarcoma virus CT10 oncogene homolog-like (CRKL). Oncol Res. 2018;26:987\u201396.","journal-title":"Oncol Res"},{"key":"7430_CR11","doi-asserted-by":"publisher","first-page":"111553","DOI":"10.1016\/j.biopha.2021.111553","volume":"139","author":"S Ghafouri-Fard","year":"2021","unstructured":"Ghafouri-Fard S, Shaterabadi D, Abak A, Shoorei H, Bahroudi Z, Taheri M, et al. An update on the role of miR-379 in human disorders. Biomed Pharmacother. 2021;139:111553.","journal-title":"Biomed Pharmacother"},{"key":"7430_CR12","doi-asserted-by":"publisher","first-page":"162","DOI":"10.1038\/cr.2007.114","volume":"18","author":"PL Andersen","year":"2008","unstructured":"Andersen PL, Xu F, Xiao W. Eukaryotic DNA damage tolerance and translesion synthesis through covalent modifications of PCNA. Cell Res. 2008;18:162\u201373.","journal-title":"Cell Res"},{"key":"7430_CR13","doi-asserted-by":"publisher","first-page":"6469","DOI":"10.1158\/0008-5472.CAN-04-1328","volume":"64","author":"E Bassett","year":"2004","unstructured":"Bassett E, King NM, Bryant MF, Hector S, Pendyala L, Chaney SG, et al. The role of DNA polymerase \u03b7 in translesion synthesis past platinum\u2013DNA adducts in human fibroblasts. Cancer Res. 2004;64:6469\u201375.","journal-title":"Cancer Res"},{"key":"7430_CR14","first-page":"3968","volume":"59","author":"JT Reardon","year":"1999","unstructured":"Reardon JT, Vaisman A, Chaney SG, Sancar A. Efficient nucleotide excision repair of cisplatin, oxaliplatin, and Bis-aceto-ammine-dichloro-cyclohexylamine-platinum(IV) (JM216) platinum intrastrand DNA diadducts. Cancer Res. 1999;59:3968\u201371.","journal-title":"Cancer Res"},{"key":"7430_CR15","doi-asserted-by":"publisher","first-page":"4575","DOI":"10.1021\/bi000130k","volume":"39","author":"A Vaisman","year":"2000","unstructured":"Vaisman A, Masutani C, Hanaoka F, Chaney SG. Efficient translesion replication past oxaliplatin and cisplatin GpG adducts by human DNA polymerase \u03b7. Biochemistry. 2000;39:4575\u201380.","journal-title":"Biochemistry"},{"key":"7430_CR16","first-page":"213","volume":"44","author":"P Li","year":"2020","unstructured":"Li P, He C, Gao A, Yan X, Xia X, Zhou J, et al. RAD18 promotes colorectal cancer metastasis by activating the epithelial-mesenchymal transition pathway. Oncol Rep. 2020;44:213\u201323.","journal-title":"Oncol Rep"},{"key":"7430_CR17","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1016\/j.canlet.2017.12.034","volume":"417","author":"S Zou","year":"2018","unstructured":"Zou S, Yang J, Guo J, Su Y, He C, Wu J, et al. RAD18 promotes the migration and invasion of esophageal squamous cell cancer via the JNK-MMPs pathway. Cancer Lett. 2018;417:65\u201374.","journal-title":"Cancer Lett"},{"key":"7430_CR18","doi-asserted-by":"publisher","first-page":"3809","DOI":"10.1002\/cam4.4754","volume":"11","author":"X Li","year":"2022","unstructured":"Li X, Zou S, Zhou L, Gao A, Xu J, He C. et al. RAD18 confers radioresistance of esophagus squamous cell carcinoma through regulating p-DNA-PKcs. Cancer Med. 2022;11:3809\u201319. https:\/\/doi.org\/10.1002\/cam4.4754.","journal-title":"Cancer Med"},{"key":"7430_CR19","doi-asserted-by":"publisher","first-page":"e84941","DOI":"10.1371\/journal.pone.0084941","volume":"9","author":"J Liao","year":"2014","unstructured":"Liao J, Qian F, Tchabo N, Mhawech-Fauceglia P, Beck A, Qian Z, et al. Ovarian cancer spheroid cells with stem cell-like properties contribute to tumor generation, metastasis and chemotherapy resistance through hypoxia-resistant metabolism. PLoS ONE. 2014;9:e84941.","journal-title":"PLoS ONE"},{"key":"7430_CR20","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1016\/S0027-5107(97)00244-3","volume":"398","author":"W Zhu","year":"1998","unstructured":"Zhu W, Yamasaki H, Mironov N. Frequency of HPRT gene mutations induced by N-methyl-N\u2032-nitro-N-nitrosoguanidine corresponds to replication error phenotypes of cell lines. Mutat Res Fundam Mol Mech Mutagen. 1998;398:93\u20139.","journal-title":"Mutat Res Fundam Mol Mech Mutagen"},{"key":"7430_CR21","doi-asserted-by":"publisher","first-page":"e1043482.","DOI":"10.1080\/23723556.2015.1043482","volume":"3","author":"AK Srivastava","year":"2016","unstructured":"Srivastava AK, Wang QE. Targeting translesion synthesis to facilitate the eradication of ovarian cancer stem cells by platinum-based therapy. Mol Cell Oncol. 2016;3:e1043482. https:\/\/doi.org\/10.1080\/23723556.2015.1043482.","journal-title":"Mol Cell Oncol"},{"key":"7430_CR22","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1186\/s12943-017-0601-3","volume":"16","author":"C Gasch","year":"2017","unstructured":"Gasch C, Ffrench B, O\u2019Leary JJ, Gallagher MF. Catching moving targets: cancer stem cell hierarchies, therapy-resistance & considerations for clinical intervention. Mol Cancer. 2017;16:43.","journal-title":"Mol Cancer"},{"key":"7430_CR23","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1016\/j.semcancer.2017.03.003","volume":"44","author":"A Agliano","year":"2017","unstructured":"Agliano A, Calvo A, Box C. The challenge of targeting cancer stem cells to halt metastasis. Semin Cancer Biol. 2017;44:25\u201342.","journal-title":"Semin Cancer Biol"},{"key":"7430_CR24","doi-asserted-by":"publisher","first-page":"788","DOI":"10.1016\/j.molcel.2011.07.026","volume":"43","author":"H Yanagihara","year":"2011","unstructured":"Yanagihara H, Kobayashi J, Tateishi S, Kato A, Matsuura S, Tauchi H. et al. NBS1 recruits RAD18 via a RAD6-like domain and regulates Pol \u03b7-dependent translesion DNA synthesis. Mol Cell. 2011;43:788\u201397. https:\/\/doi.org\/10.1016\/j.molcel.2011.07.026.","journal-title":"Mol Cell"},{"key":"7430_CR25","doi-asserted-by":"publisher","unstructured":"Chien J, Kuang R, Landen C, Shridhar V. Platinum-sensitive recurrence in ovarian cancer: the role of tumor microenvironment. Front Oncol. 2013;3. https:\/\/doi.org\/10.3389\/fonc.2013.00251.","DOI":"10.3389\/fonc.2013.00251"},{"key":"7430_CR26","doi-asserted-by":"publisher","first-page":"10002","DOI":"10.1002\/jcp.27885","volume":"234","author":"Z Asadzadeh","year":"2019","unstructured":"Asadzadeh Z, Mansoori B, Mohammadi A, Aghajani M, Haji-Asgarzadeh K, Safarzadeh E. et al. microRNAs in cancer stem cells: biology, pathways, and therapeutic opportunities. J Cell Physiol. 2019;234:10002\u201317. https:\/\/doi.org\/10.1002\/jcp.27885.","journal-title":"J Cell Physiol"},{"key":"7430_CR27","doi-asserted-by":"publisher","first-page":"3502","DOI":"10.3892\/or.2017.5607","volume":"37","author":"D Wu","year":"2017","unstructured":"Wu D, Niu X, Tao J, Li P, Lu Q, Xu A. et al. MicroRNA-379-5p plays a tumor-suppressive role in human bladder cancer growth and metastasis by directly targeting MDM2. Oncol Rep.2017;37:3502\u20138. https:\/\/doi.org\/10.3892\/or.2017.5607.","journal-title":"Oncol Rep."},{"key":"7430_CR28","doi-asserted-by":"publisher","first-page":"BSR20160542","DOI":"10.1042\/BSR20160542","volume":"37","author":"X Xie","year":"2017","unstructured":"Xie X, Li YS, Xiao WF, Deng ZH, He HB, Liu Q, et al. MicroRNA-379 inhibits the proliferation, migration and invasion of human osteosarcoma cells by targetting EIF4G2. Biosci Rep. 2017;37:BSR20160542.","journal-title":"Biosci Rep"},{"key":"7430_CR29","doi-asserted-by":"publisher","first-page":"164","DOI":"10.1186\/s13046-017-0636-8","volume":"36","author":"B Thakur","year":"2017","unstructured":"Thakur B, Ray P. Cisplatin triggers cancer stem cell enrichment in platinum-resistant cells through NF-\u03baB-TNF\u03b1-PIK3CA loop. J Exp Clin Cancer Res. 2017;36:164.","journal-title":"J Exp Clin Cancer Res"},{"key":"7430_CR30","doi-asserted-by":"publisher","first-page":"106","DOI":"10.1038\/s41419-017-0163-8","volume":"9","author":"Y Dang","year":"2018","unstructured":"Dang Y, Wang X, Hao Y, Zhang X, Zhao S, Ma J, et al. MicroRNA-379-5p is associated with biochemical premature ovarian insufficiency through PARP1 and XRCC6. Cell Death Dis. 2018;9:106.","journal-title":"Cell Death Dis"},{"key":"7430_CR31","doi-asserted-by":"publisher","first-page":"1916","DOI":"10.1111\/1759-7714.14437","volume":"13","author":"K Yang","year":"2022","unstructured":"Yang K, Li D, Jia W, Song Y, Sun N, Wang J. et al. MiR-379-5p inhibits the proliferation, migration, and invasion of breast cancer by targeting KIF4A. Thorac Cancer. 2022;13:1916\u201324.https:\/\/doi.org\/10.1111\/1759-7714.14437.","journal-title":"Thorac Cancer"},{"key":"7430_CR32","doi-asserted-by":"publisher","first-page":"833","DOI":"10.1080\/15384101.2018.1456296","volume":"17","author":"Y Yang","year":"2018","unstructured":"Yang Y, Gao Y, Zlatanou A, Tateishi S, Yurchenko V, Rogozin IB. et al. Diverse roles of RAD18 and Y-family DNA polymerases in tumorigenesis. Cell Cycle. 2018;17:833\u201343. https:\/\/doi.org\/10.1080\/15384101.2018.1456296.","journal-title":"Cell Cycle"},{"key":"7430_CR33","doi-asserted-by":"publisher","first-page":"108555","DOI":"10.1016\/j.biopha.2019.01.016","volume":"112","author":"B Wu","year":"2019","unstructured":"Wu B, Wang H, Zhang L, Sun C, Li H, Jiang C, et al. High expression of RAD18 in glioma induces radiotherapy resistance via down-regulating P53 expression. Biomed Pharmacother. 2019;112:108555.","journal-title":"Biomed Pharmacother"},{"key":"7430_CR34","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1111\/j.1755-148X.2011.00948.x","volume":"25","author":"RPC Wong","year":"2012","unstructured":"Wong RPC, Aguissa-Tour\u00e9 AH, Wani AA, Khosravi S, Martinka M, Martinka M. et al. Elevated expression of RAD18 regulates melanoma cell proliferation. Pigment Cell Melanoma Res. 2012;25:213\u20138. https:\/\/doi.org\/10.1111\/j.1755-148X.2011.00948.x.","journal-title":"Pigment Cell Melanoma Res"},{"key":"7430_CR35","doi-asserted-by":"publisher","first-page":"zcaa037","DOI":"10.1093\/narcan\/zcaa037","volume":"3:","author":"J Lou","year":"2021","unstructured":"Lou J, Yang Y, Gu Q, Price BA, Qiu Y, Fedoriw Y, et al. RAD18 mediates specific mutational signatures and shapes the genomic landscape of carcinogen-induced tumors in vivo. NAR Cancer. 2021;3::zcaa037.","journal-title":"NAR Cancer"},{"key":"7430_CR36","doi-asserted-by":"publisher","first-page":"3886","DOI":"10.1038\/sj.emboj.7600383","volume":"23","author":"K Watanabe","year":"2004","unstructured":"Watanabe K, Tateishi S, Kawasuji M, Tsurimoto T, Inoue H, Yamaizumi M. RAD18 guides pol\u03b7 to replication stalling sites through physical interaction and PCNA monoubiquitination. EMBO J. 2004;23:3886\u20133896. https:\/\/doi.org\/10.1038\/sj.emboj.7600383.","journal-title":"EMBO J"},{"key":"7430_CR37","doi-asserted-by":"publisher","first-page":"13326","DOI":"10.1038\/ncomms13326","volume":"7","author":"E Despras","year":"2016","unstructured":"Despras E, Sittewelle M, Pouvelle C, Delrieu N, Cordonnier AM, Kannouche PL. RAD18-dependent SUMOylation of human specialized DNA polymerase eta is required to prevent under-replicated DNA. Nat Commun. 2016;7:13326.","journal-title":"Nat Commun"}],"container-title":["Cell Death &amp; Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41419-025-07430-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41419-025-07430-5","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41419-025-07430-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,28]],"date-time":"2025-02-28T12:53:58Z","timestamp":1740747238000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41419-025-07430-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,2,27]]},"references-count":37,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["7430"],"URL":"https:\/\/doi.org\/10.1038\/s41419-025-07430-5","relation":{},"ISSN":["2041-4889"],"issn-type":[{"value":"2041-4889","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,2,27]]},"assertion":[{"value":"21 February 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 January 2025","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 February 2025","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 February 2025","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The author declares no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"All experiments related to patients were performed at CNCI, Kolkata. Before starting the study, the mandatory institutional human ethical clearance was taken (Ref No. CNCI-IEC-40104). Patients were made aware of the study\u2019s objectives, and their written consent was also received. Animal care and related experiments were conducted following institutional guidelines and with the approval of Ohio State University\u2019s Institutional Animal Care and Use Committee.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}}],"article-number":"140"}}